Prosecution Insights
Prosecution Insights
5 pending office actions • 5 clients • 5 examiners • 5 art units • 0 of 5 (0%) have an AI response strategy ready • 10 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (20%) |
| §102 only | 1 (20%) |
| §112 only | 2 (40%) |
| No statute on record | 1 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RICKS, DONNA J | 1 | 77.1% | +8.8% |
| OTTON, ALICIA L | 1 | 65.0% | +9.0% |
| CHONG, KIMBERLY | 1 | 72.4% | +12.7% |
| DICKENS, AMELIA NICOLE | 1 | 48.2% | +22.6% |
| ALLEN, MARIANNE P | 1 | 59.8% | +18.5% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17768138 | Natural non-pathogenic microorganisms capable of associating glycolipids or lipopeptides and use thereof | DICKENS, AMELIA NICOLE | 80d overdue |
| 16492987 | TARGET DETECTION USING A MONOVALENT ANTIBODY | ALLEN, MARIANNE P | 49d overdue |
| 18176396 | STING-DEPENDENT ACTIVATORS FOR TREATMENT OF DISEASE | CHONG, KIMBERLY | 19d overdue |
| Client (Assignee) | Pending OAs |
|---|---|
| PME IP PTY LTD | 1 |
| STINGINN INC. | 1 |
| UNIVERSITY OF MIAMI | 1 |
| ACARYON GMBH | 1 |
| NanoTag | 1 |
| Art Unit | Apps |
|---|---|
| 2618 | 1 |
| 1699 | 1 |
| 1636 | 1 |
| 1645 | 1 |
| 1647 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18424594 | MULTI-USER MULTI-GPU RENDER SERVER APPARATUS AND METHODS | Pme Ip Pty Ltd. | RICKS, DONNA J | 2618 | §103 | Non-Final OA | 59d overdue | Pending | Jan 26, 2024 |
| 18565204 | SMALL MOLECULAR INHIBITORS OF STING SIGNALING COMPOSITIONS AND METHODS OF USE | Stinginn Inc. | OTTON, ALICIA L | 1699 | §102 | Non-Final OA | 23d overdue | Pending | Nov 29, 2023 |
| 18176396 | STING-DEPENDENT ACTIVATORS FOR TREATMENT OF DISEASE | UNIVERSITY OF MIAMI | CHONG, KIMBERLY | 1636 | Other | Non-Final OA | 19d overdue | Pending | Feb 28, 2023 |
| 17768138 | Natural non-pathogenic microorganisms capable of associating glycolipids or lipopeptides and use thereof | Acaryon GmbH | DICKENS, AMELIA NICOLE | 1645 | §112 | Non-Final OA | 80d overdue | Pending | Apr 11, 2022 |
| 16492987 | TARGET DETECTION USING A MONOVALENT ANTIBODY | Nanotag Biotechnologies GmbH | ALLEN, MARIANNE P | 1647 | §112 | Non-Final OA | 49d overdue | Pending | Sep 11, 2019 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial